Itai Danovitch
Overview
Explore the profile of Itai Danovitch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1069
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer A, Truman K, Totlani J, William C, Brown H, Shah S, et al.
Int J Psychiatry Med
. 2024 Dec;
:912174241310091.
PMID: 39703084
Objective: The purpose of this systematic review is to provide a detailed summary of the long-acting injectable antipsychotic medications approved by the Food and Drug Administration (FDA) between 2008 to...
2.
IsHak W, Mirocha J, Dang J, Vanle B, Metrikin B, Tessema K, et al.
Psychiatr Res Clin Pract
. 2024 Nov;
6(3):68-77.
PMID: 39568501
Objective: Psychiatric disorders are associated with impairments in quality of life (QOL) and functioning. What remained to be investigated was the comparison of these constructs across psychiatric disorders in treatment-seeking...
3.
IsHak W, Meyer A, Freire L, Totlani J, Murphy N, Renteria S, et al.
Innov Clin Neurosci
. 2024 Sep;
21(7-9):27-47.
PMID: 39329027
Objective: This systematic review provides an overview of psychiatric medications in the late stages of development (Phase III clinical trials) as of June 1, 2024. It details the mechanisms of...
4.
Danovitch I, Fortuna L, Gomez-Luna S, Metz P, Waller C
Health Aff (Millwood)
. 2024 Jul;
43(7):1052.
PMID: 38950297
No abstract available.
5.
Evans S, Ober A, Korn A, Peltz A, Friedmann P, Page K, et al.
Addict Sci Clin Pract
. 2024 Apr;
19(1):31.
PMID: 38671482
Background: Hospitalization presents an opportunity to begin people with opioid use disorder (OUD) on medications for opioid use disorder (MOUD) and link them to care after discharge; regrettably, people admitted...
6.
Danovitch I, Korouri S, Kaur H, Messineo G, Nuckols T, Ishak W, et al.
J Subst Use Addict Treat
. 2024 Apr;
163:209377.
PMID: 38657952
Introduction: The Addiction Consultation Service has emerged as a model of care for hospitalized patients with substance use disorder. The aim of this integrative review is to characterize the Addiction...
7.
IsHak W, Hamilton M, Korouri S, Diniz M, Mirocha J, Hedrick R, et al.
JAMA Netw Open
. 2024 Jan;
7(1):e2352094.
PMID: 38231511
Importance: Heart failure (HF) affects more than 6 million adults in the US and more than 64 million adults worldwide, with 50% prevalence of depression. Patients and clinicians lack information...
8.
IsHak W, Garcia P, Pearl R, Dang J, William C, Totlani J, et al.
Innov Clin Neurosci
. 2023 Jun;
20(4-6):39-48.
PMID: 37387703
Objective: This systematic review aims to evaluate the impact of psilocybin on patients experiencing psychiatric symptoms, with a focus on health-related quality of life (HRQoL) and safety. Method Of Research:...
9.
Spiegel B, Fuller G, Liu X, Dupuy T, Norris T, Bolus R, et al.
J Pain
. 2023 Jun;
24(10):1745-1758.
PMID: 37330159
We compared the effectiveness of physician-directed clinical decision support (CDS) administered via electronic health record versus patient-directed education to promote the appropriate use of opioids by conducting a cluster-randomized trial...
10.
Ober A, Osilla K, Klein D, Burgette L, Leamon I, Mazer M, et al.
J Subst Use Addict Treat
. 2023 May;
150:209063.
PMID: 37156424
Objectives: We conducted a pilot randomized controlled trial (RCT) to explore whether a hospital inpatient addiction consult team (Substance Use Treatment and Recovery Team [START]) based on collaborative care was...